Secondary
Sangamo Therapeutics
We are a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using our industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy.
Symbol
SGMO
Last Closing Price
$16.25
Anticipated Date
TBD
Underwriters
BofA Merrill Lynch, J.P. Morgan, Cowen
To view the prospectus for Sangamo Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277